CYPH Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-0.020.0% YoY
Profit margin0.0%FINANCIAL SERVICES
Market cap$78.8MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 0.97
- P/S (TTM)
- 160.10
- EV/EBITDA
- 11.21
Profitability & growth
- ROE (TTM)
- -108.2%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- -0.02
Last earnings
May 14, 2026 · Reported $-0.46
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
49 articles · sorted by datePage 1 of 3 · 49 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Cypherpunk Technologies Inc.
Company profileCypherpunk Technologies Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
Classification
- Sector
- Financial Services
- Industry
- Asset Management
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 47 THORNDIKE STREET, CAMBRIDGE, MA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$78.8M
Shares outstanding$106.5M
52W high$3.70
52W low$0.23
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent